Novartis

Tecfidera Raises The Bar For Biogen Idec

Tecfidera Raises The Bar For Biogen Idec

Seeking Alpha

Will This Court Decision Be a Thorn in the Side of Novartis?

Will This Court Decision Be a Thorn in the Side of Novartis?

Wall St. Cheat Sheet

Novartis loses landmark India patent case on Glivec

Novartis loses landmark India patent case on Glivec

Reuters

Pfizer's Next Big Deal Will Generate Income For Novartis, Prevent Competitors' Initiative

Pfizer's Next Big Deal Will Generate Income For Novartis, Prevent Competitors' Initiative

Seeking Alpha

FDA Approves Novartis' TOBI Podhaler

FDA Approves Novartis' TOBI Podhaler

Yahoo/Zacks

How Much Will FDA Action On Invokana Affect Johnson And Johnson's Revenue And Stock Price?

How Much Will FDA Action On Invokana Affect Johnson And Johnson's Revenue And Stock Price?

Seeking Alpha

4 Stocks Dragging The Drugs Industry Downward

4 Stocks Dragging The Drugs Industry Downward

TheStreet.com

Novartis, GlaxoSmithKline top Big Pharma's 'freshness' index of new drug sales

Novartis, GlaxoSmithKline top Big Pharma's 'freshness' index of new drug sales

Fierce Pharma

GSK
Novartis

Drug Companies Have Rebounded From The Patent Cliff With Acquisitions Now On The Mind

Drug Companies Have Rebounded From The Patent Cliff With Acquisitions Now On The Mind

Seeking Alpha

U.K. Regulators Sour on Novartis Breast Cancer Drug Afinitor

U.K. Regulators Sour on Novartis Breast Cancer Drug Afinitor

Motley Fool